| Natural products in licorice for the therapy of liver diseases: Progress and future opportunities X Li, R Sun, R Liu Pharmacological Research 144, 210-226, 2019 | 246 | 2019 |
| Cholangiocyte‐derived exosomal long noncoding RNA H19 promotes hepatic stellate cell activation and cholestatic liver fibrosis R Liu, X Li, W Zhu, Y Wang, D Zhao, X Wang, EC Gurley, G Liang, ... Hepatology 70 (4), 1317-1335, 2019 | 215 | 2019 |
| The role of sphingosine 1‐phosphate receptor 2 in bile‐acid–induced cholangiocyte proliferation and cholestasis‐induced liver injury in mice Y Wang, H Aoki, J Yang, K Peng, R Liu, X Li, X Qiang, L Sun, EC Gurley, ... Hepatology 65 (6), 2005-2018, 2017 | 206 | 2017 |
| Conjugated bile acid–activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression M Nagahashi, K Takabe, R Liu, K Peng, X Wang, Y Wang, NC Hait, ... Hepatology 61 (4), 1216-1226, 2015 | 204 | 2015 |
| Colonic inflammation and secondary bile acids in alcoholic cirrhosis G Kakiyama, PB Hylemon, H Zhou, WM Pandak, DM Heuman, DJ Kang, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 306 (11 …, 2014 | 197 | 2014 |
| Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1‐phosphate receptor 2 R Liu, R Zhao, X Zhou, X Liang, DJW Campbell, X Zhang, L Zhang, R Shi, ... Hepatology 60 (3), 908-918, 2014 | 185 | 2014 |
| A comprehensive review and perspectives on pharmacology and toxicology of saikosaponins X Li, X Li, N Huang, R Liu, R Sun Phytomedicine 50, 73-87, 2018 | 178 | 2018 |
| Cholangiocyte‐derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans X Li, R Liu, Z Huang, EC Gurley, X Wang, J Wang, H He, H Yang, G Lai, ... Hepatology 68 (2), 599-615, 2018 | 147 | 2018 |
| Long noncoding RNA H19 contributes to cholangiocyte proliferation and cholestatic liver fibrosis in biliary atresia Y Xiao, R Liu, X Li, EC Gurley, PB Hylemon, Y Lu, H Zhou, W Cai Hepatology 70 (5), 1658-1673, 2019 | 133 | 2019 |
| ER stress and hepatic lipid metabolism H Zhou, R Liu Frontiers in genetics 5, 112, 2014 | 131 | 2014 |
| Continued Alcohol Misuse in Human Cirrhosis is Associated with An Impaired Gut‐Liver Axis JS Bajaj, G Kakiyama, D Zhao, H Takei, A Fagan, P Hylemon, H Zhou, ... Alcoholism: Clinical and Experimental Research, 2017 | 125 | 2017 |
| Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice DJ Kang, NS Betrapally, SA Ghosh, RB Sartor, PB Hylemon, PM Gillevet, ... Hepatology 64 (4), 1232-1248, 2016 | 111 | 2016 |
| Cholangiocyte-derived exosomal lncRNA H19 promotes macrophage activation and hepatic inflammation under cholestatic conditions X Li, R Liu, Y Wang, W Zhu, D Zhao, X Wang, H Yang, EC Gurley, W Chen, ... Cells 9 (1), 190, 2020 | 103 | 2020 |
| Neuroinflammation in Murine Cirrhosis is Dependent on the Gut Microbiome and is Attenuated by Fecal Transplant. R Liu, JD Kang, BR Sartor, M Sikaroodi, A Fagan, EA Gavis, H Zhou, ... Hepatology, 2019 | 102 | 2019 |
| The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice X Li, R Liu, J Yang, L Sun, L Zhang, Z Jiang, P Puri, EC Gurley, G Lai, ... Hepatology 66 (3), 869-884, 2017 | 102 | 2017 |
| Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytes Y Wang, X Zhou, D Zhao, X Wang, EC Gurley, R Liu, X Li, PB Hylemon, ... PLoS One 15 (5), e0232630, 2020 | 95 | 2020 |
| Taurocholate induces cyclooxygenase-2 expression via the sphingosine 1-phosphate receptor 2 in a human cholangiocarcinoma cell line R Liu, X Li, X Qiang, L Luo, PB Hylemon, Z Jiang, L Zhang, H Zhou Journal of Biological Chemistry 290 (52), 30988-31002, 2015 | 86 | 2015 |
| Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease X Li, J Ge, Y Li, Y Cai, Q Zheng, N Huang, Y Gu, Q Han, Y Li, R Sun, R Liu Acta Pharmaceutica Sinica B 11 (11), 3527-3541, 2021 | 69 | 2021 |
| Advances in the study of emodin: an update on pharmacological properties and mechanistic basis Q Zheng, S Li, X Li, R Liu Chinese Medicine 16, 1-24, 2021 | 67 | 2021 |
| Toxicity of traditional Chinese medicine herbal and mineral products R Liu, X Li, N Huang, M Fan, R Sun Advances in Pharmacology 87, 301-346, 2020 | 63 | 2020 |
Huiping Zhou, Ph.D; ProfessorVirginia commonwealth UniversityВерификована је имејл адреса на vcu.edu